Kyongbo Pharmaceutical Revenue

In the year 2024, Kyongbo Pharmaceutical had annual revenue of 238.56B KRW with 10.26% growth. Kyongbo Pharmaceutical had revenue of 59.31B in the quarter ending December 31, 2024, a decrease of -3.19%.

Revenue

238.56B

Revenue Growth

+10.26%

P/S Ratio

0.56

Revenue / Employee

n/a

Employees

n/a

Market Cap

132.44B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	238.56B	22.20B	10.26%
Dec 31, 2023	216.36B	20.09B	10.24%
Dec 31, 2022	196.26B	25.61B	15.00%
Dec 31, 2021	170.66B	-44.63B	-20.73%
Dec 31, 2020	215.29B	23.58B	12.30%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	68.13B
Peptron	3.15B
LigaChem Biosciences	125.90B

Revenue Rankings